Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
22 Mai 2023 - 10:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May, 2023
Commission File Number 001-39809
MEDIROM HEALTHCARE
TECHNOLOGIES INC.
(Translation of registrant’s name into English)
2-3-1 Daiba, Minato-ku
Tokyo 135-0091, Japan
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
x Form 20-F
¨ Form 40-F
INFORMATION
CONTAINED IN THIS FORM 6-K REPORT
Issuance of Press Release
On May 22, 2023, MEDIROM Healthcare Technologies Inc. (the “Company”)
issued a press release announcing its major Key Performance Indicators, or KPIs, updated for the month of April 2023.
The press release furnished as Exhibit 99.1 to this report on Form
6-K shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that section.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
MEDIROM Healthcare Technologies
Inc. |
Date: May 22, 2023 |
|
|
|
By: |
/s/ Fumitoshi Fujiwara |
|
|
Name: Fumitoshi Fujiwara |
|
|
Title: Chief Financial Officer |
MEDIROM Healthcare Techn... (NASDAQ:MRM)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
MEDIROM Healthcare Techn... (NASDAQ:MRM)
Historical Stock Chart
Von Jun 2023 bis Jun 2024